AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Marius Zemaitis

Marius Zemaitis

Lithuanian University of Health Sciences - Kaunas / Lithuania
Others
AD Scientific Index ID: 4993646
Lietuvos sveikatos mokslų universitetas
person_outline Marius Zemaitis's MOST POPULAR ARTICLES
1-) Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … The Lancet 393 (10183), 1819-1830, 2019
2-) Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer BMC immunology 19 (1), 3, 2018
3-) Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma Lung cancer 54 (1), 109-116, 2006
4-) Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease BMC immunology 14 (1), 36, 2013
5-) Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine Lung Cancer 56 (1), 115-123, 2007